Monte Rosa Therapeutics, Inc.

GLUE

—

Advanced chart & tools →

Monte Rosa Therapeutics, Inc.GLUE

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.96

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$123.67M

Net income

$-38.63M

Net margin

-31.2%

Gross margin

—

Dividends & financials

Monte Rosa Therapeutics, Inc. (GLUE) reported revenue of $123.67M and net income of $-38.63M, or $-2.96 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.